Selected research
Industry Research
Ziprasidone Industry Research Report 2026
Market perspective
The global Ziprasidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ziprasidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ziprasidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ziprasidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ziprasidone include Apotex, Aurobindo, Dr. Reddy's Laboratories, Lupin Pharmaceuticals, Macleods Pharmaceuticals, Wockhardt, Zydus Pharmaceuticals, Pfizer and Mylan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ziprasidone market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ziprasidone Market by Company
Apotex
Aurobindo
Dr. Reddy's Laboratories
Lupin Pharmaceuticals
Macleods Pharmaceuticals
Wockhardt
Zydus Pharmaceuticals
Pfizer
Mylan Pharmaceuticals
Sandoz
Ziprasidone Segment by Type
Oral Capsule
Injection
Ziprasidone Segment by Application
Hospital
Drug Store
Ziprasidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ziprasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ziprasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ziprasidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ziprasidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ziprasidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ziprasidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Capsule
- Injection
Applications
- Hospital
- Drug Store
Companies covered
- Apotex
- Aurobindo
- Dr. Reddy's Laboratories
- Lupin Pharmaceuticals
- Macleods Pharmaceuticals
- Wockhardt
- Zydus Pharmaceuticals
- Pfizer
- Mylan Pharmaceuticals
- Sandoz
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ziprasidone Market Size (2021-2032)
- 2.2.2 Global Ziprasidone Sales (2021-2032)
- 2.2.3 Global Ziprasidone Market Average Price (2021-2032)
- 2.3 Ziprasidone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Capsule
- 2.3.3 Injection
- 2.4 Ziprasidone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ziprasidone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ziprasidone Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Ziprasidone Revenue of Manufacturers (2021-2026)
- 3.4 Global Ziprasidone Average Price by Manufacturers (2021-2026)
- 3.5 Global Ziprasidone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ziprasidone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ziprasidone, Product Type & Application
- 3.8 Global Manufacturers of Ziprasidone, Established Date
- 3.9 Global Ziprasidone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Apotex
- 4.1.1 Apotex Company Information
- 4.1.2 Apotex Business Overview
- 4.1.3 Apotex Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Apotex Ziprasidone Product Portfolio
- 4.1.5 Apotex Recent Developments
- 4.2 Aurobindo
- 4.2.1 Aurobindo Company Information
- 4.2.2 Aurobindo Business Overview
- 4.2.3 Aurobindo Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Aurobindo Ziprasidone Product Portfolio
- 4.2.5 Aurobindo Recent Developments
- 4.3 Dr. Reddy's Laboratories
- 4.3.1 Dr. Reddy's Laboratories Company Information
- 4.3.2 Dr. Reddy's Laboratories Business Overview
- 4.3.3 Dr. Reddy's Laboratories Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dr. Reddy's Laboratories Ziprasidone Product Portfolio
- 4.3.5 Dr. Reddy's Laboratories Recent Developments
- 4.4 Lupin Pharmaceuticals
- 4.4.1 Lupin Pharmaceuticals Company Information
- 4.4.2 Lupin Pharmaceuticals Business Overview
- 4.4.3 Lupin Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lupin Pharmaceuticals Ziprasidone Product Portfolio
- 4.4.5 Lupin Pharmaceuticals Recent Developments
- 4.5 Macleods Pharmaceuticals
- 4.5.1 Macleods Pharmaceuticals Company Information
- 4.5.2 Macleods Pharmaceuticals Business Overview
- 4.5.3 Macleods Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Macleods Pharmaceuticals Ziprasidone Product Portfolio
- 4.5.5 Macleods Pharmaceuticals Recent Developments
- 4.6 Wockhardt
- 4.6.1 Wockhardt Company Information
- 4.6.2 Wockhardt Business Overview
- 4.6.3 Wockhardt Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Wockhardt Ziprasidone Product Portfolio
- 4.6.5 Wockhardt Recent Developments
- 4.7 Zydus Pharmaceuticals
- 4.7.1 Zydus Pharmaceuticals Company Information
- 4.7.2 Zydus Pharmaceuticals Business Overview
- 4.7.3 Zydus Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zydus Pharmaceuticals Ziprasidone Product Portfolio
- 4.7.5 Zydus Pharmaceuticals Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Ziprasidone Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Mylan Pharmaceuticals
- 4.9.1 Mylan Pharmaceuticals Company Information
- 4.9.2 Mylan Pharmaceuticals Business Overview
- 4.9.3 Mylan Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan Pharmaceuticals Ziprasidone Product Portfolio
- 4.9.5 Mylan Pharmaceuticals Recent Developments
- 4.10 Sandoz
- 4.10.1 Sandoz Company Information
- 4.10.2 Sandoz Business Overview
- 4.10.3 Sandoz Ziprasidone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sandoz Ziprasidone Product Portfolio
- 4.10.5 Sandoz Recent Developments
5 Global Ziprasidone Market Scenario by Region
- 5.1 Global Ziprasidone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ziprasidone Sales by Region: 2021-2032
- 5.2.1 Global Ziprasidone Sales by Region: 2021-2026
- 5.2.2 Global Ziprasidone Sales by Region: 2027-2032
- 5.3 Global Ziprasidone Revenue by Region: 2021-2032
- 5.3.1 Global Ziprasidone Revenue by Region: 2021-2026
- 5.3.2 Global Ziprasidone Revenue by Region: 2027-2032
- 5.4 North America Ziprasidone Market Facts & Figures by Country
- 5.4.1 North America Ziprasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ziprasidone Sales by Country (2021-2032)
- 5.4.3 North America Ziprasidone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Ziprasidone Market Facts & Figures by Country
- 5.5.1 Europe Ziprasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ziprasidone Sales by Country (2021-2032)
- 5.5.3 Europe Ziprasidone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Ziprasidone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ziprasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ziprasidone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ziprasidone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ziprasidone Market Facts & Figures by Country
- 5.7.1 South America Ziprasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ziprasidone Sales by Country (2021-2032)
- 5.7.3 South America Ziprasidone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Ziprasidone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ziprasidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ziprasidone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ziprasidone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Ziprasidone Sales by Type (2021-2032)
- 6.1.1 Global Ziprasidone Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Ziprasidone Sales Market Share by Type (2021-2032)
- 6.2 Global Ziprasidone Revenue by Type (2021-2032)
- 6.2.1 Global Ziprasidone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ziprasidone Revenue Market Share by Type (2021-2032)
- 6.3 Global Ziprasidone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ziprasidone Sales by Application (2021-2032)
- 7.1.1 Global Ziprasidone Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Ziprasidone Sales Market Share by Application (2021-2032)
- 7.2 Global Ziprasidone Revenue by Application (2021-2032)
- 7.2.1 Global Ziprasidone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ziprasidone Revenue Market Share by Application (2021-2032)
- 7.3 Global Ziprasidone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ziprasidone Value Chain Analysis
- 8.1.1 Ziprasidone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ziprasidone Production Mode & Process
- 8.2 Ziprasidone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ziprasidone Distributors
- 8.2.3 Ziprasidone Customers
9 Global Ziprasidone Analyzing Market Dynamics
- 9.1 Ziprasidone Industry Trends
- 9.2 Ziprasidone Industry Drivers
- 9.3 Ziprasidone Industry Opportunities and Challenges
- 9.4 Ziprasidone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst